Neuroblastomas (NB) are pediatric malignancies with heterogenous phenotypes, ranging from spontaneously regressing to highly aggressive, incurable tumors. Although NB is considered a genetic disease, its etiology and heterogeneity cannot be explained solely by genetic aberrations. NB arises due to defects in sympathetic neuron (SN) differentiation occurring during fetal development. Strikingly, despite the presence of genetic aberrations, NB cells undergo neuronal differentiation when subjected to proper factors. Thus, differentiation defects seem to be independent of genetic changes and can arise due to abnormalities in fetal environment. Strikingly, the two factors promoting de-differentiation of NB cells, hypoxia and glucocorticoids, are elevated in the fetus during maternal stress, suggesting a role for prenatal stress in NB development. Moreover, both hypoxia and glucocorticoids up-regulate neuropeptide Y (NPY), the sympathetic neurotransmitter acting as a mitogenic and survival factor for NB. In line with this, we have found that corticosterone treatment, as well as subjecting pregnant mice to stress associated with experimental procedures alone, increased tumorigenicity in their hemizygous TH-MYCN offspring from 32 to 64%. The role of maternal stress during pregnancy in promoting NB development is further supported by epidemiological data. Increased frequency of NB has been associated with low and high birth weights. Low birth weight is a common sign of prenatal stress, while high birth weight is most often caused by gestational diabetes. Notably both of these conditions are associated with elevated fetal cortisol. Hence, we hypothesize that prenatal stress leads to the blocking of SN differentiation and accumulation of neuroblasts by changing the fetal microenvironment. This, in turn, promotes NB formation by augmenting effects of pre-existing mutations and facilitating accumulation of further genetic changes. To test our hypothesis, we will 1) Determine the effect of prenatal stress on NB development; 2) Identify candidate mediators of its actions and 3) Elucidate the mechanism of this tumorigenic effect. To test the effect of prenatal stress on NB development we will use TH-MYCN mice, which spontaneously develop NB. The mothers during pregnancy will be chronically stressed and tumor frequencies will be compared between their prenatally-stressed and control hemizygous offspring. To identify mediators of the stress effect, we will determine stress-induced changes in concentrations of known stress mediators and overall metabolic alterations in mothers and their offspring. Then, we will test the impact of the candidate stress mediators on SN differentiation, as well as proliferation and survival of neuroblasts and NB cells from prenatally stressed and control animals. We will also determine stress-induced phenotypic and molecular changes in tumors. To our knowledge, this is the first study addressing the role for prenatal stress in NB development. If successful, our research will identify novel pathways involved in NB etiology, which in turn may open new therapeutic opportunities and pioneer preventative approaches for NB - both pharmacological and behavioral.

Public Health Relevance

Although neuroblastoma, a childhood tumor often associated with unfavorable prognosis, is believed to be genetic in nature, there are clinical and experimental data indicating a contribution of thus far unknown non- genetic factors to its development. We propose that maternal stress during pregnancy interferes with proper neuronal development, which exacerbates effects of genetic aberrations and promotes neuroblastoma formation. If proven, this new paradigm will enhance our understanding of neuroblastoma etiology and may have broad clinical implications, including identification of new populations at risk for NB development, as well as designing novel therapies and pioneering preventative approaches for neuroblastoma - both pharmacological and behavioral stress management modalities, proven to be safe in pregnant women and effective in stress cessation.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
1R21CA198698-01
Application #
8958817
Study Section
Special Emphasis Panel (ZCA1)
Program Officer
Espey, Michael G
Project Start
2015-07-01
Project End
2017-06-30
Budget Start
2015-07-01
Budget End
2016-06-30
Support Year
1
Fiscal Year
2015
Total Cost
Indirect Cost
Name
Georgetown University
Department
Biochemistry
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Paiva, Sara P C; Veloso, Clara A; Campos, Fernanda F C et al. (2016) Elevated levels of neuropeptide Y in preeclampsia: A pilot study implicating a role for stress in pathogenesis of the disease. Neuropeptides 55:127-35
Tilan, Jason; Kitlinska, Joanna (2016) Neuropeptide Y (NPY) in tumor growth and progression: Lessons learned from pediatric oncology. Neuropeptides 55:55-66
Czarnecka, Magdalena; Kitlinska, Joanna (2016) Cell Surface Protein Detection to Assess Receptor Internalization. Bio Protoc 6:
Hong, Sung-Hyeok; Tilan, Jason U; Galli, Susana et al. (2016) In Vivo Model for Testing Effect of Hypoxia on Tumor Metastasis. J Vis Exp :
Galli, Susana; Naranjo, Arlene; Van Ryn, Collin et al. (2016) Neuropeptide Y as a Biomarker and Therapeutic Target for Neuroblastoma. Am J Pathol 186:3040-3053
Day, Jonathan; Savani, Soham; Krempley, Benjamin D et al. (2016) Influence of paternal preconception exposures on their offspring: through epigenetics to phenotype. Am J Stem Cells 5:11-8